HomeFile

File

View Category
Acute coronary syndromes

Cardiovascular Events Reduction: Bivalirudin or Heparin?

The MATRIX study did not find a clear advantage of bivalirudin over unfractioned heparin to reduce major...
solaci -
Learn More
Chronic Ischemic cardiopathy

How to Make Radial Access Even Safer with Minimum Effort

Courtesy of Dr. Agustín Vecchia.   Since 1990, radial access has progressively gained ground, currently becoming the default technique in most...
solaci -
Learn More
Acute coronary syndromes

Rechanneling a CTO in a Non-Infarct-Related Artery After Primary PCI: Yes or No?

Between 10% and 15% of patients admitted with ST-segment elevation myocardial infarction present concurrent coronary chronic total...
solaci -
Learn More
Femoral

Bioresorbable Scaffolds: Promising in Peripheral Territory

Bioresorbable Vascular Scaffolds (BVS) could change the paradigm of peripheral angioplasty according to several small studies suggesting...
solaci -
Learn More
Femoral

Paclitaxel Drug Coated Balloon in Femoral: Effective at Long Term?

In patients with symptomatic peripheral vascular disease, the paclitaxel coated balloon showed superior efficacy at 3 years...
solaci -
Learn More
Mitral valve

Percutaneous Device Closure of PVL: An Alternative to Surgery

Paravalvular Leak (PVL) occurs in 5 to 17% of patients undergoing surgical valve replacement. Percutaneous device closure...
solaci -
Learn More
Antiplatelet

Is It Safe to Discontinue Ticagrelor One Day Before CABG?

Courtesy of Dr. Agustín Vecchia. Nearly 10% of patients with acute coronary syndrome (ACS) require surgery. Managing periprocedural...
solaci -
Learn More
Structural heart disease

Late Mortality in TAVR Is Mainly Due to Non-Cardiac Causes

Transcatheter aortic valve replacement (TAVR) has revolutionized the management of high-risk patients with severe aortic stenosis. However,...
solaci -
Learn More